Originally FDA-approved for type 2 diabetes, several now carry indications for weight management and cardiovascular risk reduction
If you believe that you are eligible for Semaglutide GLP-1 injections , consider scheduling an appointment with your provider and explicitly inquire about weight loss or Semaglutide GLP-1
These data are promising, but they should not be oversold
A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026: ZEISS China tour (Changsha, Shanghai, and Hangzhou, April ZEISS APAC User Meeting) RCOphth Annual Congress May Manchester ZEISS EMEA User Meeting (Istanbul) ZEISS Lausanne User Meeting (Lausanne) European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London) Speak to Our Consultant-Led Team If you take a GLP-1 medication and have noticed any change in your vision, do not wait to have it checked
6, WW reported its third-quarter results for fiscal 2025
J., Henderson, V
